Cas:500-55-0 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl atropate manufacturer & supplier

Chemical Name:8-Methyl-8-azabicyclo[3.2.1]oct-3-yl atropate

CAS.NO:500-55-0

Synonyms:Apohyoscyamine;atropic acid tropane-3endo-yl ester;Atropamin;Apoatropin;Atropasaeure-tropan-3endo-ylester;Atropyltropeine;Benzeneacetic acid, α-methylene-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester;Propenoic acid, 2-phenyl-, 8-methyl-8-azabicyclo[3.2.1]octan-3-yl ester;8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester;8-Methyl-8-azabicyclo[3.2.1]oct-3-yl atropate;Apohyoscyamin;Benzeneacetic acid, α-methylene-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, endo-;Tropine,atropate (ester);Apoatropine;Atropamine

Molecular Formula:C₁₇H₂₁NO₂

Molecular Weight:271.354

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:389.1±42.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.572

PSA:29.54000

Exact Mass:271.157227

LogP:3.22

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1544

Packing Group:

Contact us for information like Apohyoscyamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Atropamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Atropyltropeine Use and application,Apohyoscyamin technical grade,usp/ep/jp grade.

Related News: Wavelength, a more than 30-year-old firm based in Petah Tikva, launched its API CDMO business in early 2020 and currently sports more than 250 customers from 50 countries. Nuclease, ribonucleate maturation endoribo- (Callisthene fasciculatagene matK fragment) manufacturers Exploring biocatalysis options at the start of a project is a pragmatic operational strategy to achieve the right product, at the right quality, with exceptional efficiency. H-(γ-Glu-Cys)5-Gly-OH suppliers Contract research organisation Charles River Laboratories International Inc. today announced plans for an €8M expansion of its testing capabilities at its Ballina, Co. Mayo site that will give an additional 1,500m2 of lab space and create up to 90 new skilled roles over the next three years. 4,4′-Aethandiyldioxy-bis-benzolsulfonsaeure-bis-methylamid vendor & factory Contract research organisation Charles River Laboratories International Inc. today announced plans for an €8M expansion of its testing capabilities at its Ballina, Co. Mayo site that will give an additional 1,500m2 of lab space and create up to 90 new skilled roles over the next three years.,Sales for Tafinlar and Mekinist, the MEK inhibitor it was approved with, hit $672 million in 2016. Fast forward to 2020 and the duo generated $1.5 billion in revenue.